Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew T James

Showing results (231-240 of 240) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 240 results.
Journal of Patient-Reported Outcomes|August 28, 2024
APPROACH e-PROM system: a user-centered development and evaluation of an electronic patient-reported outcomes measurement system for management of coronary artery diseaseAndrew Roberts, Eleanor Benterud, Maria J Santana, et al.
Canadian Journal of Kidney Health and Disease|November 21, 2022
Involving Patient Partners in the KRESCENT Peer Review: Intent, Process, Challenges, and OpportunitiesElisabeth A Fowler, Karin Bell, Kevin Burns, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|October 27, 2022
Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational studyMin Jun, Anish Scaria, Jason Andrade, et al.
CMAJ Open|December 12, 2019
Preferences for a self-management e-health tool for patients with chronic kidney disease: results of a patient-oriented consensus workshopMaoliosa Donald, Heather Beanlands, Sharon Straus, et al.
Kidney360|April 9, 2025
Safety and Effectiveness of Apixaban versus Warfarin by Kidney Function in Atrial Fibrillation: A Binational Population-Based StudyDickson Lam, Anish Scaria, Jason Andrade, et al.
The Journal of Clinical Investigation|June 5, 2018
Renal immune surveillance and dipeptidase-1 contribute to contrast-induced acute kidney injuryArthur Lau, Hyunjae Chung, Takanori Komada, et al.
Kidney Medicine|July 26, 2023
Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and CanadaJeffrey T Ha, Anish Scaria, Jason Andrade, et al.
The Canadian Journal of Cardiology|June 22, 2021
2021 Update on Safety of Magnetic Resonance Imaging: Joint Statement From Canadian Cardiovascular Society/Canadian Society for Cardiovascular Magnetic Resonance/Canadian Heart Rhythm Society, D Ian Paterson, James A White, et al.
Clinical Medicine (London, England)|April 1, 2026
Renin-Angiotensin System inhibitors (RASi) are not nephrotoxic - they protect the kidneys and the heartJonathan S Murray, Paul R Kalra, Lisa J Anderson, et al.
The Science of the Total Environment|May 30, 2026
Longitudinal wastewater-based surveillance of vancomycin-resistant Enterococci in tertiary-care hospitalsEmily Au, Nicole Acosta, Barbara J Waddell, et al.
Pageof 24

Showing results (231-240 of 240) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 240 results.
Journal of Patient-Reported Outcomes|August 28, 2024
APPROACH e-PROM system: a user-centered development and evaluation of an electronic patient-reported outcomes measurement system for management of coronary artery diseaseAndrew Roberts, Eleanor Benterud, Maria J Santana, et al.
Canadian Journal of Kidney Health and Disease|November 21, 2022
Involving Patient Partners in the KRESCENT Peer Review: Intent, Process, Challenges, and OpportunitiesElisabeth A Fowler, Karin Bell, Kevin Burns, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|October 27, 2022
Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational studyMin Jun, Anish Scaria, Jason Andrade, et al.
CMAJ Open|December 12, 2019
Preferences for a self-management e-health tool for patients with chronic kidney disease: results of a patient-oriented consensus workshopMaoliosa Donald, Heather Beanlands, Sharon Straus, et al.
Kidney360|April 9, 2025
Safety and Effectiveness of Apixaban versus Warfarin by Kidney Function in Atrial Fibrillation: A Binational Population-Based StudyDickson Lam, Anish Scaria, Jason Andrade, et al.
The Journal of Clinical Investigation|June 5, 2018
Renal immune surveillance and dipeptidase-1 contribute to contrast-induced acute kidney injuryArthur Lau, Hyunjae Chung, Takanori Komada, et al.
Kidney Medicine|July 26, 2023
Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and CanadaJeffrey T Ha, Anish Scaria, Jason Andrade, et al.
The Canadian Journal of Cardiology|June 22, 2021
2021 Update on Safety of Magnetic Resonance Imaging: Joint Statement From Canadian Cardiovascular Society/Canadian Society for Cardiovascular Magnetic Resonance/Canadian Heart Rhythm Society, D Ian Paterson, James A White, et al.
Clinical Medicine (London, England)|April 1, 2026
Renin-Angiotensin System inhibitors (RASi) are not nephrotoxic - they protect the kidneys and the heartJonathan S Murray, Paul R Kalra, Lisa J Anderson, et al.
The Science of the Total Environment|May 30, 2026
Longitudinal wastewater-based surveillance of vancomycin-resistant Enterococci in tertiary-care hospitalsEmily Au, Nicole Acosta, Barbara J Waddell, et al.
Pageof 24